UCSF Parnassus
Welcome,         Profile    Billing    Logout  
 8 Trials 
29 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Klein, Liviu
NCT04194632: Right Ventricular Pacing in Pulmonary Arterial Hypertension

Recruiting
N/A
16
US
Temporary right ventricular pacing
University of California, San Francisco
Pulmonary Artery Hypertension, Right Ventricular Dysfunction
12/21
12/21
DETECT-HF, NCT06378632: AN INTERNATIONAL, OBSERVATIONAL, BLINDED STUDY TO ASSESS THE PERFORMANCE OF THE CORDIO HEARO SYSTEM

Recruiting
N/A
500
Europe, US, RoW
Hearo App
Cordio Medical
Heart Failure
01/25
03/25
Rebalance-HF, NCT04592445: Endovascular Ablation of the Right Greater Splanchnic Nerve in Subjects Having HFpEF

Recruiting
N/A
80
US
Satera GSN Ablation, Sham Control
Axon Therapies, Inc.
Heart Failure With Preserved Ejection Fraction
04/22
03/23
NCT04223934: Tailored Drug Titration Using Artificial Intelligence

Completed
N/A
164
US
optima4BP
Optima Integrated Health, University of California, San Francisco
Hypertension
12/22
06/23
LVAD-SilverD, NCT05163392: A Silver Lining in the VAD Sky

Recruiting
N/A
20
US
Silverlon, Control
University of California, San Francisco, International Consortium of Circulatory Assist Clinicians
LVAD (Left Ventricular Assist Device) Driveline Infection
12/23
12/23
NCT05206422: DORAYA-HF Early Feasibility Study

Recruiting
N/A
30
US
Doraya Catheter
Revamp Medical Inc.
Acute Decompensated Heart Failure
10/25
12/25
CorCinch-HF, NCT04331769: Clinical Evaluation of the AccuCinch® Ventricular Restoration System in Patients Who Present with Symptomatic Heart Failure with Reduced Ejection Fraction (HFrEF): the CORCINCH-HF Study

Recruiting
N/A
400
Europe, US, RoW
AccuCinch Ventricular Restoration System, Guideline-Directed Medical Therapy
Ancora Heart, Inc.
Heart Failure with Reduced Ejection Fraction (HFrEF), Dilated Cardiomyopathy
12/26
12/30
REVERSE-HF, NCT05318105: Ultrafiltration Versus IV Diuretics in Worsening Heart Failure

Recruiting
N/A
372
US
Aquadex Smartflow® System, IV Loop Diuretics
Nuwellis, Inc.
Heart Failure (for Example, Fluid Overload)
07/25
10/25
NCT03523416: Early Feasibility Study - Edwards APTURE Transcatheter Shunt System

Active, not recruiting
N/A
71
US
Transcatheter Atrial Shunt System
Edwards Lifesciences
Heart Failure
12/23
11/28
NCT05047068: OCS Heart Perfusion Post-Approval Registry

Active, not recruiting
N/A
350
US
OCS Heart System
TransMedics
Transplant
12/25
12/29
ReDS-HF, NCT03586336: Remote Dielectric Sensing (ReDS) Assisted Diuresis in Acute Decompensated Heart Failure

Recruiting
N/A
100
US
ReDS-Guided, Usual Care
University of California, San Francisco, Sensible Medical Innovations Ltd.
Heart Failure; With Decompensation
12/25
12/25
rēST Study, NCT03884660: Remedē System Therapy Study

Recruiting
N/A
500
Europe, US
remede System
Respicardia, Inc.
Central Sleep Apnea
06/27
06/32
OHP-II, NCT05915299: US National OCS Heart Perfusion (OHP) Registry

Recruiting
N/A
100000
US
OCS Heart
TransMedics
Heart Transplant
08/29
08/33
Wong, Christopher
MVP-ANOCA, NCT06424834: Efficacy of Targeted Medical Therapy in Angina and Nonobstructive Coronary Arteries

Recruiting
2/3
150
US
Amlodipine, Norvasc, Katerzia, Norliqva, Nebivolol, Bystolic, Placebo
Stanford University, American Heart Association
Angina Pectoris, Microvascular Angina, Vasospastic Angina, Myocardial Bridge of Coronary Artery
12/26
12/26
ACTRN12621000208808: Effect of SGLT2 Inhibition With Empagliflozin on Atrial Fibrillation Severity (SWEET-AF)

Recruiting
2
300
 
The University of Adelaide , The Hospital Research Foundation, National Heart Foundation
Atrial Fibrillation
 
 
DECAF, NCT05121519: Does Eliminating Coffee Avoid Fibrillation?

Active, not recruiting
N/A
200
US
Consume coffee, Avoid coffee
University of California, San Francisco
Atrial Fibrillation, Coffee
10/25
10/25
ACTRN12621001204831: Coronary Physiology and Imaging to Identify the Culprit Artery in Non-ST Elevation Myocardial Infarction: The CAPTURE-NSTEMI pilot study

Not yet recruiting
N/A
50
 
Royal Prince Alfred Hospital, Royal Prince Alfred Hospital, Abbott Vascular
Coronary heart disease
 
 
ACTRN12617000199314: Assessment and management of obstructive sleep apnoea following bariatric surgery

Recruiting
N/A
200
 
Christopher Wong, Joondalup Health Campus
Obstructive sleep apnoea, Obesity
 
 
ACTRN12619000450112: The Macro- and Micro-circulation in Coronary Heart Disease

Recruiting
N/A
600
 
Royal Prince Alfred Hospital (Sydney Local Health District), Royal Prince Alfred Hospital (Sydney Local Health D=iIstrict)
Coronary heart disease
 
 
NCT05063474: Microvascular Reactivity in Peripheral Artery Disease

Terminated
N/A
3
US
No Intervention-Clinical Assessments only
Columbia University, Agency for Healthcare Research and Quality (AHRQ)
Peripheral Artery Disease
04/23
04/23
Marcus, Greg
WIRE-IT, NCT04645342: Wire Instrumentation Using Radiofrequency Energy to Impact Transseptal Efficiency

Completed
N/A
75
US
Baylis Versacross RF wire, Baylis RF needle
University of California, San Francisco, Baylis Medical Company
Atrial Fibrillation, Atrial Flutter
02/22
02/22
NCT05866731: The Heart Rhythm Twins Study

Recruiting
N/A
120
US
University of California, San Francisco
Premature Atrial Complex, Premature Ventricular Contraction
01/25
01/25
DECAF, NCT05121519: Does Eliminating Coffee Avoid Fibrillation?

Active, not recruiting
N/A
200
US
Consume coffee, Avoid coffee
University of California, San Francisco
Atrial Fibrillation, Coffee
10/25
10/25
VIBRANT-AF, NCT05504356: Volunteers to Investigate Best Results for Ablation and Novel Therapies for Atrial Fibrillation

Recruiting
N/A
1125
US
University of California, San Francisco, American College of Cardiology
Atrial Fibrillation
07/26
07/27
Wong, Chris
ACTRN12620000285954: Effect of Iron Repletion in Symptomatic Patients with Atrial Fibrillation (IRON-AF)

Recruiting
4
84
 
University of Adelaide, University of Adelaide
Atrial fibrillation, Iron deficiency
 
 
DECAF, NCT05121519: Does Eliminating Coffee Avoid Fibrillation?

Active, not recruiting
N/A
200
US
Consume coffee, Avoid coffee
University of California, San Francisco
Atrial Fibrillation, Coffee
10/25
10/25
Klien, Liviu
LVAD-SilverD, NCT05163392: A Silver Lining in the VAD Sky

Recruiting
N/A
20
US
Silverlon, Control
University of California, San Francisco, International Consortium of Circulatory Assist Clinicians
LVAD (Left Ventricular Assist Device) Driveline Infection
12/23
12/23
Wei, Ying
NCT05195918: Study of Oral Epigallocatechin-3-gallate (EGCG) in IPF Patients

Recruiting
1
50
US
EGCG 300 mg + Nintedanib, epigallocatechin-3-gallate + Ofev, EGCG 300 mg + Pirfenidone, epigallocatechin-3-gallate + Esbriet, Placebo 2 capsules + Nintedanib or Pirfenidone, Placebo + Ofev or Esbriet, EGCG 600 mg + Nintedanib, EGCG 600 mg + Pirfenidone, Placebo 4 capsules + Nintedanib or Pirfenidone
Hal Chapman, University of Michigan, Cornell University, Massachusetts General Hospital, Temple University, University of Washington, University of Virginia
Idiopathic Pulmonary Fibrosis
04/26
04/26
Chapman, Harold
NCT05195918: Study of Oral Epigallocatechin-3-gallate (EGCG) in IPF Patients

Recruiting
1
50
US
EGCG 300 mg + Nintedanib, epigallocatechin-3-gallate + Ofev, EGCG 300 mg + Pirfenidone, epigallocatechin-3-gallate + Esbriet, Placebo 2 capsules + Nintedanib or Pirfenidone, Placebo + Ofev or Esbriet, EGCG 600 mg + Nintedanib, EGCG 600 mg + Pirfenidone, Placebo 4 capsules + Nintedanib or Pirfenidone
Hal Chapman, University of Michigan, Cornell University, Massachusetts General Hospital, Temple University, University of Washington, University of Virginia
Idiopathic Pulmonary Fibrosis
04/26
04/26

Download Options